Application Nr Approved Date Route Status External Links
ANDA202949 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: •major Depressive Disorder [See Clinical Studies (14.1)] •generalized Anxiety Disorder [See Clinical Studies (14.2)] •diabetic Peripheral Neuropathy [See Clinical Studies (14.3)] •chronic Musculoskeletal Pain [See Clinical Studies (14.5)] Duloxetine Delayed-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For: Major Depressive Disorder (Mdd) (1) Generalized Anxiety Disorder (Gad) (1) Diabetic Peripheral Neuropathic Pain (Dpnp) (1) Chronic Musculoskeletal Pain (1).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Duloxetine Hydrochloride DULOXETINE HYDROCHLORIDE ZINC1536779

Comments